A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid Tumors

NCT06209385 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

157

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: YZJ-5053 tablets

Sponsor

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.